Centerpoint Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21K Hold
944
0.01% 255
2026
Q1
$21K Hold
944
0.01% 229
2025
Q4
$22K Hold
944
0.01% 226
2025
Q3
$25K Hold
944
0.01% 214
2025
Q2
$27K Hold
944
0.01% 201
2025
Q1
$24K Hold
944
0.01% 220
2024
Q4
$21K Buy
944
+472
+100% +$10.2K 0.01% 258
2024
Q3
$10K Hold
472
﹤0.01% 354
2024
Q2
$9K Hold
472
﹤0.01% 352
2024
Q1
$9K Hold
472
﹤0.01% 327
2023
Q4
$10K Hold
472
﹤0.01% 327
2023
Q3
$10K Hold
472
﹤0.01% 336
2023
Q2
$11K Buy
+472
New +$10.8K ﹤0.01% 333

Other funds holding FMS

Centerpoint Advisors's FMS Position: Q2 2026 in Review

Centerpoint Advisors held its Fresenius Medical Care (FMS) position steady in Q2 2026 at 944 shares worth $21K. The position accounts for 0.01% of the portfolio, ranked #255.

Centerpoint Advisors first reported a position in FMS in Q2 2023 and has held it in 13 quarters since. The position peaked at $27K in Q2 2025. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Centerpoint Advisors held 944 shares of Fresenius Medical Care worth $21K as of Q2 2026.
  • Centerpoint Advisors left its Fresenius Medical Care share count unchanged in Q2 2026.
  • Fresenius Medical Care made up 0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #255 holding.
  • Centerpoint Advisors first reported a position in Fresenius Medical Care in Q2 2023 and has held it in 13 quarters since.
  • Centerpoint Advisors's Fresenius Medical Care position peaked at $27K in Q2 2025.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.